AXA SA (CS.PA)

FR0000120628 - Common Stock

29.43  -1.52 (-4.91%)

Fundamental Rating

5

Overall CS gets a fundamental rating of 5 out of 10. We evaluated CS against 34 industry peers in the Insurance industry. CS has only an average score on both its financial health and profitability. CS is not valued too expensively and it also shows a decent growth rate. CS also has an excellent dividend rating. This makes CS very considerable for dividend investing!



6

1. Profitability

1.1 Basic Checks

In the past year CS was profitable.
CS had a positive operating cash flow in the past year.
CS had positive earnings in each of the past 5 years.
In the past 5 years CS always reported a positive cash flow from operatings.

1.2 Ratios

CS has a Return On Assets of 1.09%. This is in the better half of the industry: CS outperforms 63.64% of its industry peers.
With a decent Return On Equity value of 14.13%, CS is doing good in the industry, outperforming 60.61% of the companies in the same industry.
CS has a Return On Invested Capital of 1.21%. This is in the better half of the industry: CS outperforms 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CS is in line with the industry average of 2.11%.
Industry RankSector Rank
ROA 1.09%
ROE 14.13%
ROIC 1.21%
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%

1.3 Margins

CS has a Profit Margin of 8.23%. This is comparable to the rest of the industry: CS outperforms 45.45% of its industry peers.
CS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 11.15%, CS is in line with its industry, outperforming 57.58% of the companies in the same industry.
CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.15%
PM (TTM) 8.23%
GM N/A
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
Compared to 1 year ago, CS has less shares outstanding
Compared to 5 years ago, CS has less shares outstanding
Compared to 1 year ago, CS has a worse debt to assets ratio.

2.2 Solvency

CS has an Altman-Z score of 0.32. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
CS has a better Altman-Z score (0.32) than 87.88% of its industry peers.
The Debt to FCF ratio of CS is 3.74, which is a good value as it means it would take CS, 3.74 years of fcf income to pay off all of its debts.
CS has a Debt to FCF ratio of 3.74. This is comparable to the rest of the industry: CS outperforms 57.58% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that CS is not too dependend on debt financing.
The Debt to Equity ratio of CS (0.49) is better than 69.70% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 3.74
Altman-Z 0.32
ROIC/WACC0.12
WACC10.49%

2.3 Liquidity

A Current Ratio of 0.99 indicates that CS may have some problems paying its short term obligations.
CS has a Current ratio of 0.99. This is amongst the best in the industry. CS outperforms 84.85% of its industry peers.
CS has a Quick Ratio of 0.99. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 0.99, CS belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.99

4

3. Growth

3.1 Past

CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.00%, which is quite good.
Measured over the past 5 years, CS shows a small growth in Earnings Per Share. The EPS has been growing by 4.77% on average per year.
The Revenue for CS has decreased by -15.52% in the past year. This is quite bad
CS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.57% yearly.
EPS 1Y (TTM)12%
EPS 3Y23.02%
EPS 5Y4.77%
EPS Q2Q%34.3%
Revenue 1Y (TTM)-15.52%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.57%
Sales Q2Q%-18.71%

3.2 Future

CS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.08% yearly.
Based on estimates for the next years, CS will show a small growth in Revenue. The Revenue will grow by 2.81% on average per year.
EPS Next Y10.3%
EPS Next 2Y8.67%
EPS Next 3Y8.57%
EPS Next 5Y6.08%
Revenue Next Year-7.52%
Revenue Next 2Y-9.06%
Revenue Next 3Y-4.69%
Revenue Next 5Y2.81%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.56 indicates a reasonable valuation of CS.
63.64% of the companies in the same industry are more expensive than CS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CS to the average of the S&P500 Index (28.39), we can say CS is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.09, the valuation of CS can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CS is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 19.91, CS is valued rather cheaply.
Industry RankSector Rank
PE 9.56
Fwd PE 8.09

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.21
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CS may justify a higher PE ratio.
PEG (NY)0.93
PEG (5Y)2
EPS Next 2Y8.67%
EPS Next 3Y8.57%

7

5. Dividend

5.1 Amount

CS has a Yearly Dividend Yield of 5.93%, which is a nice return.
CS's Dividend Yield is a higher than the industry average which is at 5.39.
CS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 5.93%

5.2 History

The dividend of CS has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3

5.3 Sustainability

56.37% of the earnings are spent on dividend by CS. This is a bit on the high side, but may be sustainable.
CS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.37%
EPS Next 2Y8.67%
EPS Next 3Y8.57%

AXA SA

EPA:CS (6/14/2024, 7:00:00 PM)

29.43

-1.52 (-4.91%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap66.84B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 5.93%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.56
Fwd PE 8.09
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.93
PEG (5Y)2
Profitability
Industry RankSector Rank
ROA 1.09%
ROE 14.13%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.15%
PM (TTM) 8.23%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.99
Quick Ratio 0.99
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)12%
EPS 3Y23.02%
EPS 5Y
EPS Q2Q%
EPS Next Y10.3%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.52%
Revenue growth 3Y-7.69%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y